L. V.
- Country
- The Netherlands
- Department
- Medische Oncologie
Research Overview
- Phase III Multicenter Randomized Trial of Dose-Reduced Chemotherapy with Fluorouracil, Folinic Acid, Capecitabine, and Oxaliplatin in Metastatic Colorectal Cancer
- Phase 2 Randomized Study of Liposomal Irinotecan, Carboplatin, and Oxaliplatin in First-Line Treatment of Metastatic or Locally Advanced Esophagogastric Cancer
Data & Insights
Has run more than one trial at 25 of 56 partner sites.
Specializations
Oncology Focus
The investigator specializes in treating metastatic colorectal cancer, demonstrating particular expertise in developing treatment approaches for advanced stages of the disease.
- Advanced Colorectal Cancer Management
- Personalized Treatment Strategies
- Chemotherapy Optimization
Their research interests encompass therapeutic interventions for colorectal cancer patients, with special attention to treatment adaptation and efficacy.
Geriatric Oncology
A significant focus of the investigator's work involves cancer treatment in older patients, particularly exploring adaptive therapeutic approaches for this specific population.
- Age-Specific Treatment Protocols
- Risk Assessment in Elderly Patients
- Treatment Tolerance Optimization
The investigator's expertise extends to developing specialized treatment strategies that consider the unique needs of elderly cancer patients.
Treatment Innovation
The investigator explores adaptive chemotherapy approaches, focusing on optimizing treatment protocols through dose modification strategies.
- Chemotherapy Dosing Strategies
- Treatment Efficacy Assessment
- Multi-Center Clinical Research
Their work encompasses the development of innovative treatment protocols that balance therapeutic efficacy with patient tolerance.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.